Research Type: Extramural
Professor Reddel and the team will analyse the proteins in a person’s cancer to help doctors choose the most effective treatment for each patient.
Dr Sarah Hancock and the team are focusing on a weakness in pancreatic cancer linked to how cancer cells make and use fats to survive.
Dr Donia Moujalled and the team are testing a new antibody–drug conjugate (ADC) designed to deliver a powerful anticancer drug directly into leukaemia cells while limiting harm to healthy cells.
A/Prof Justin Wong and his team is aiming to develop a new treatment strategy to prevent and treat fatty liver disease and stop its progression to liver cancer.
A/Prof Liz Caldon and her team is focusing on finding a better treatment option for people whose breast cancer has become resistant to CDK4/6 inhibitors.
A/Prof Frances Byrne and her team are testing a new approach to treat liver cancer by targeting obesity alongside existing cancer therapies.
Prof John Pimanda and the team are aiming to help existing treatments work better for people with acute myeloid leukemia (AML), especially those who do not respond well to current medicines.
Prof Phillips and team are developing a new “two-in-one” RNA nanomedicine designed to tackle treatment resistance from two angles at the same time.
A/Prof Charles de Bock and his team are developing new immune-based treatments that help the body’s own immune system find and destroy leukaemia cells.
Prof Fernandez-Peñas’ group aims to develop a scar-free method for assessing moles using a gentle tape-based biopsy that collects skin cells without cutting the skin.